Adverse events following 12 and 18 month vaccinations: A population-based, self-controlled case series analysis

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Wilson, Kumanan ^a,b,c   Hawken, Steven ^a   Kwong, Jeffrey C ^d   Deeks, Shelley ^e   Crowcroft, Natasha S ^e   van Walraven, Carl ^a,b   Potter, Beth K ^a,b   Chakraborty, Pranesh ^b,c   Keelan, Jennifer ^f   Pluscauskas, Michael ^c   Manuel, Doug ^a,b,g  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CANADA; CASE CONTROL STUDY; CHILD; CHILD HEALTH CARE; CHILD HOSPITALIZATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; EMERGENCY WARD; FEBRILE CONVULSION; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MUMPS; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRESCHOOL CHILD; RISK ASSESSMENT; RUBELLA; VACCINATION REACTION; BIOASSAY; HEALTH SURVEY; HOSPITALIZATION; RISK FACTOR; STATISTICS; TIME; VACCINATION;

ENDPOINT DETERMINATION; HOSPITALIZATION; HUMANS; INFANT; POPULATION SURVEILLANCE; RISK FACTORS; TIME FACTORS; VACCINATION;

EID: 83155183239     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027897     Document Type: Article

References (21)

1. Stratton KR, Howe CJ, Johnston RB, eds. (1994) Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Washington, DC National Academy Press.
2. Siegrist CA, (2007) Mechanisms underlying adverse reactions to vaccines. J Comp Pathol 137 (Suppl 1): S46-50.
3. Strebel PM, Papania MJ, Halsey NA, (2004) Measles vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed Philadelphia Saunders.
4. Fritzell B, (2001) Detection of adverse events: what are the current sensitivity limits during clinical development? Vaccine 20 (Suppl 1): S47-48.
5. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, et al. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345: 656-661.
6. Vestergaard M, Hviid A, Madsen KM, Wohlfahrt J, Thorsen P, et al. (2004) MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. Jama 292: 351-357.
7. Farrington P, Pugh S, Colville A, Flower A, Nash J, et al. (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345: 567-569.
8. Whitaker HJ, Farrington CP, Spiessens B, Musonda P, (2006) Tutorial in biostatistics: the self-controlled case series method. Stat Med 25: 1768-1797.
9. Virtanen M, Peltola H, Paunio M, Heinonen OP, (2000) Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics 106: E62.
10. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126: e1-8.
11. Abdi H, (2007) "Bonferroni and Šidák corrections for multiple comparisons". In: Salkind NJ, editors. Encyclopedia of Measurement and Statistics Thousand Oaks, CA Sage.
12. Warren DW, Jarvis A, LeBlanc L, Gravel J, (2008) Revisions to the Canadian Triage and Acuity Scale paediatric guidelines (PaedCTAS). Cjem 10: 224-243.
13. Fine PE, Chen RT, (1992) Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 136: 121-135.
14. Davis RL, Marcuse E, Black S, Shinefield H, Givens B, et al. (1997) MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics 100: 767-771.
15. Centres for Disease Control and Prevention Possible Side-effects from Vaccines (http://www.cdc.gov/vaccines/vac-gen/side-effects.htm#dtap). Accessed 2011 Nov14.
16. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W, (1991) Risk of seizures after measles-mumps-rubella immunization. Pediatrics 88: 881-885.
17. Farrington CP, Nash J, Miller E, (1996) Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 143: 1165-1173.
18. Wilson K, Hawken S, Potter BK, Chakraborty P, Kwong J, et al. (2011) Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations- a population based study of 969,519 vaccination events. Vaccine 29: 3746-3752.
19. Shui IM, Shi P, Dutta-Linn MM, Weintraub ES, Hambidge SJ, et al. (2009) Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine 27: 5307-5312.
20. Koskiniemi M, Korppi M, Mustonen K, Rantala H, Muttilainen M, et al. (1997) Epidemiology of encephalitis in children. A prospective multicentre study. Eur J Pediatr 156: 541-545.
21. Public Health Agency of Canada (2006) 7th Ed Canadian Immunization Guide.